Bye Bye CFDA, Hello NMPA: China Regulatory Express

In the latest in a series of regulatory changes in China, the national drugs regulator has apparently been renamed the National Medical Products Administration (NMPA), while the country's essential drugs list has been expanded to include more oncology and pediatric drugs, which will be fully reimbursed.

Chinese flag
China renames CFDA, Expands essential drug list • Source: Shutterstock

More from China

More from Asia